SCOPUS 정보 검색 플랫폼 - 논문 보기

메뉴 건너뛰기

Drug Information Journal

Volumn 34, Issue 3, 2000, Pages 681-692

The food and drug administration modernization act and the food and drug administration: Metamorphosis or makeover?

(1) Milne, C P a

a TUFTS UNIVERSITY SCHOOL OF MEDICINE (United States)

Author keywords

FDA Modernization Act; FDAMA; Food and Drug Administration; Rule making

Indexed keywords

ARTICLE; DRUG INDUSTRY; DRUG RESEARCH; FOOD AND DRUG ADMINISTRATION; LAW; POLICY; PRIORITY JOURNAL; REGULATORY MECHANISM;

EID: 0033846850 PISSN: 00928615 EISSN: None Source Type: Journal
DOI: 10.1177/009286150003400304 Document Type: Article

Times cited : (5)

References (49)

1
- 0008217386
- Food and Drug Administration Modernization and Accountability Act of 1997 Senate Report 105-43, to accompany S 830, Committee on Labor and Human Resources, 105th Congress, 1st Session

2
- 0008177166
- Food and Drug Modernization Act of 1997, Summary prepared by the Biotechnology Industry Organization
- (1997)

3
- 0008262416
- Prepared statement of Alan Holmer, President of the Pharmaceutical Research and Manufacturers of America (PhRMA), before the House Commerce Committee
- (1998)

4
- 4244152346
- Loose cannons
- (1998) BioCentury , vol.6 , Issue.21

5
- 84996175482
- FDA and industry embark on new collaborative era
- (1998) Reg Aff Focus , vol.3 , Issue.1 , pp. 18-21
- Robinson, M.L.¹

6
- 0030908349
- An FDA perspective on the drug development process
- (1997) Food and Drug Law J , vol.52 , Issue.2 , pp. 145-150
- Woodcock, J.¹

7
- 0030965818
- Science and regulatory rituals associated with the drug development process
- (1997) Food and Drug Law J , vol.52 , Issue.2 , pp. 155-161
- Versteegh, L.R.¹

8
- 0008256197
- Opening Statement of Chairman James M. Jeffords, Hearing on FDA Modernization Act: implementation of the law, Senate Health, Education, Labor and Pensions Committee
- (1999)

9
- 0032517645
- Investigational New Drug Applications; clinical holds
- (1998) Federal Register , vol.63 , Issue.239 , pp. 68676

10
- 0008178021
- Prepared statement of Alan Holmer, President of the Pharmaceutical Research and Manufacturers of America, before the Senate Committee on Health, Education, Labor, and Pension
- (1999)

11
- 0008258870
- Converting to regulation by guidance
- (1998) Pharma Marketletter , vol.25 , Issue.42 , pp. 15

12
- 0008177168
- Guidance for industry: qualifying for pediatric exclusivity under section 505A of the Federal Food, Drug, and Cosmetic Act Rockville, MD: Food and Drug Administration
- (1999)

13
- 0008217387
- Guidance for industry: qualifying for pediatric exclusivity under section 505A of the Federal Food, Drug, and Cosmetic Act. Rockville, MD: Food and Drug Administration
- (1998)

14
- 0008280017
- Industry active role in guidance development urged by Wyeth's Burlington
- (1999) Pink Sheet , vol.61 , Issue.40 , pp. 24

15
- 0008261883
- Prepared Statement by Jane E. Henney, MD, Commissioner of Food and Drugs, Food and Drug Administration, before the Senate Committee on Health, Education, Labor and Pensions
- (1999)

16
- 0008220182
- Food and Drug Administration, Summary of FDA Public Meeting on Section 406(b) of FDA Modernization Act of 1997
- (1998)

17
- 0008218932
- CBER Stakeholders Meeting, Summary of Proceedings
- (1998)

18
- 0008178023
- Opening Statement of Edward M. Kennedy, Hearing on FDA Modernization Act: Implementation of the Law
- (1999)

19
- 0032909035
- FDAMA update
- (1999) Food and Drug Law J , vol.54 , Issue.1 , pp. 21-33
- Suydam, L.A.¹ Elder, D.K.²

20
- 0008220367
- Federal Administrative Procedure Act, 5 U.S.C. section551 et seq., sectionsec 551 (4)
- (1991)

21
- 0008177782
- Administrative Practice and Procedure. Second Edition. Charlottesville VA; Michie
- (1991) , pp. 627-628
- Koch, C.H.¹

22
- 0008176659
- Administrative Law and Process. 3rd Edition. St. Paul, MN: West
- (1991) , pp. 310
- Gellhorn, E.¹ Levin, R.M.²

23
- 0008261337
- Testimony of Ms. Janice Bourque, Massachusetts Biotechnology Council, Hearing on the Modernization of the Food and Drug Administration, before the Senate Health, Education, Labor and Pensions Committee
- (1999)

24
- 4243065621
- Modernizing the FDA: An incremental revolution
- (1999) Health Aff. , vol.18 , Issue.2 , pp. 96-111
- Merrill, R.A.¹

25
- 0033004552
- One large, well-designed, multicenter study as an alternative to the usual FDA paradigm
- (1999) Drug Inf J , vol.33 , Issue.1 , pp. 265-271
- Fisher, L.D.¹

26
- 0008248605
- Guidance for industry: providing clinical evidence of effectiveness for human drug and biological products. Rockville, MD: Food and Drug Administration
- (1998)

27
- 0008280020
- Prescription Drug User Fee Reauthorization and Drug Regulatory Modernization Act of 1997, House Report 105-310, to accompany H.R. 1411, 105th Congress, 1st Session

28
- 0008218934
- Guidance for industry: standards for the prompt review of efficacy supplements, including priority efficacy supplements. Rockville, MD: Food and Drug Administration
- (1998)

29
- 0008258872
- FY 1998 Performance report to Congress for the Prescription Drug User Fee Act of 1992 as amended by the FDA Modernization Act of 1997. Rockville, MD: Food and Drug Administration
- (1999)

30
- 0008218935
- Efficacy supplements approved in CY 99. Rockville, MD: Food and Drug Administration; Center for Drug Evaluation and Research
- (1999)

31
- 0008175177
- Efficacy supplements approved in CY 98. Rockville, MD: Food and Drug Administration; Center for Drug Evaluation and Research
- (1998)

32
- 0032553158
- Dissemination of information on unapproved/new uses for marketed drugs, biologics, and devices; final role
- (1998) Federal Register , vol.63 , Issue.224 , pp. 64555

33
- 0008255767
- Remicade off-label RA campaign cleared with balancing statement
- (1999) Pink Sheet , vol.61 , Issue.23 , pp. 3-4

34
- 0008183583
- United States District Court for the District of Columbia, Washington Legal Foundation v. Jane E. Henney and Donna Shalala, Order Granting Summary Judgment and Permanent Injunction, Civil Action No.1:94CV01306 (RCL)

35
- 0008214711
- Testimony of Jane Henney, Commissioner, Food and Drug Administration, Hearing on the Modernization of the Food and Drug Administration, before the Senate Health, Education, Labor and Pensions Committee
- (1999)

36
- 84996189939
- Sailing the straits, Henney on FDA, FDAMA and marketing
- (1998) Pharma Exec. Dec. , vol.18 , Issue.12 , pp. 42-48
- Wechsler, J.¹

37
- 0032476883
- Regulations requiring manufacturers to assess the safety and effectiveness of new drugs and biological products in pediatric patients
- (1998) Federal Register , vol.63 , Issue.231 , pp. 66632

38
- 0008262418
- Remarks by Linda Suydam, Senior Associate Commissioner, Food and Drug Administration, presented at Food and Drug Law Institute, Educational Conference, Washington, D.C.
- (1999)

39
- 0032878337
- Pediatric research: Coming of age in the new millennium
- (1999) Am J Therapeutics , vol.6 , Issue.5 , pp. 263-282
- Milne, C.-P.¹

40
- 0008178024
- Standard NDA reviews most affected by downturn in first-cycle NDA approvals Lumpkin asserts
- (1999) U.S. Reg Reporter , vol.16 , Issue.4 , pp. 1-3

41
- 0031894352
- Faster access to chugs for serious or life-threatening illnesses through use of the accelerated approval regulation in the United States
- (1998) Drug Inf J , vol.32 , Issue.1 , pp. 27-35
- Cocchetto, D.M.¹ Jones, D.R.²

42
- 0030840825
- Initiatives to speed new drug development and regulatory review: The impact of FDA-sponsor conferences
- (1997) Drug Inf J , vol.31 , Issue.3 , pp. 771-788
- DiMasi, J.A.¹ Manocchia, M.²

43
- 0008175178
- Fast track drugs may lose designation if criteria are no longer met-FDA
- (1998) Pink Sheet , vol.60 , Issue.47 , pp. 32

44
- 0008177172
- Ombudsman's corner: CDER's pet peeves - Part II
- (2000) News Along the Pike , vol.6 , Issue.1 , pp. 3
- Morrison, J.¹

45
- 0003192925
- An interview with Director of the Division of Cardio-Renal Drug Products Raymond Lipicky, MD
- (1999) U.S. Reg Reporter , vol.16 , Issue.4 , pp. 3-7

46
- 84996165603
- Patients or profits?
- (1998) Economist , vol.7 , pp. 15

47
- 0032740491
- The European Agency for the Evaluation of Medicinal Products' centralized procedure for product approval: Current status
- (1999) Drug Inf J , vol.33 , Issue.4 , pp. 969-978
- Healy, E.M.¹ Kaitin, K.I.²

48
- 0008223804
- Pharma outpaced in global rankings
- (1999) Scrip , vol.2454 , pp. 9

49
- 0008280024
- US retail Rx sales to rise 18%
- (1999) Scrip , vol.2470 , pp. 15

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.